Relief Therapeutics forms executive committee.

Relief Therapeutics, a rare disease biopharmaceutical company, announced the formation of a new executive committee, strengthening its team with appointments of a CFO, CHRO, and Head of Legal and Compliance. Andrew Einhorn joins as CFO, bringing extensive experience from senior leadership roles in clinical and commercial-stage life science companies. This expansion aims to guide the company through pipeline development initiatives.

May 08, 2024
5 Articles